Clinical and laboratory characteristics of a new influenza A (HIN1) epidemic.
- Author:
Yan-Qing FENG
1
;
Tong-Sheng GUO
;
Li-Ming LIU
;
Yong-Li LI
;
Bo LI
;
Zhi-Guo LIU
;
Zhi-Qiang SUN
;
Min ZHAO
;
Yuan-Li MAO
;
Bo-An LI
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Disease Outbreaks; Female; Humans; Influenza A Virus, H1N1 Subtype; drug effects; pathogenicity; Influenza, Human; diagnosis; drug therapy; virology; Male; Oseltamivir; therapeutic use; Young Adult
- From: Chinese Journal of Experimental and Clinical Virology 2010;24(2):134-135
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo analysis the clinical and laboratory characteristics of Patients infected with new influenza A (HIN1) virus.
METHODSAll cases with new influenza A (H1N1) confirmed on polymerase chain reaction assay on throat swabs. There were included in a prospective evaluation of clinical characteristics, laboratory results, treatment and overcome of new influenza A (H1N1).
RESULTSThere were 35 patients in the epidemic. Clinical illness developed within a mean of 1.7 days. Fever occurred in 97.1%, sore throat 65.7% cough 51.4%, headache 28.6%, and myalgia 31.4%. All patients were treated with oseltamivir lasted 5 days. The mean duration of viral shedding was 4.5 days. All were cured and left hospital after day 7.
CONCLUSIONIt was infected by new influenza A (H1N1) typically in this epidemic.
